Aligos Therapeutics Inc (ALGS) — Strategic Asset Allocation Index
Aligos Therapeutics Inc (ALGS) has a Strategic Asset Allocation Index of 16.2% as of June 2023. Strategic assets (PP&E of $11.26 Million plus long-term investments of $-) total $11.26 Million, measured against net assets of $69.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Aligos Therapeutics Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Aligos Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 16.2%, representing strategic assets of $11.26 Million against net assets of $69.64 Million USD. Explore Aligos Therapeutics Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Aligos Therapeutics Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Aligos Therapeutics Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ALGS market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.6% | $4.82 Million | $4.82 Million | $0.00 | $103.90 Million | ▼ -11.6 pp |
| 2021 | 16.3% | $30.08 Million | $14.97 Million | $15.11 Million | $184.73 Million | ▲ +9.5 pp |
| 2020 | 6.8% | $14.91 Million | $14.91 Million | $0.00 | $220.04 Million | — |